Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...

Small Granite 4.0 models are available today, with ‘thinking,’ medium, and nano variants releasing later this year. F-Droid says Google's developer registration rule could end its open-source app ...